It also supports the growing body of evidence that confirms that immunodeficiency is an integral part of T2DM and that this compromise could have serious consequences in the face of intracellular pathogens that require type-1 associated cytokines for resistance. This evidence concerns the gene SGCG and immunodeficiency disease.